Concor
Name: Password
Back      Home     Language:

Research projects and publications

 

1.     Dr. P.G. Pieper, UMCG, Groningen: “Pregnancy in congenital heart disease”

1.1.     Drenthen W, Pieper PG, Ploeg M, Voors AA, Roos-Hesselink JW, Mulder BJ, Vliegen HW, Sollie KM, Ebels T, van Veldhuisen D. Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteries. Eur Heart J. 2005 Dec 26(23); 2588-95.

1.2.     Drenthen W, Pieper PG, van der Tuuk K, Roos-Hesselink JW, Voors AA, Mostert B, Mulder BJ, Moons P, Ebels T, van Veldhuisen DJ. Cardiac complications relating to pregnancy and recurrence of disease in the offspring of women with atrioventricular septal defects. Eur Heart J. 2005 Aug 17.

1.3.     Vriend JW, Drenthen W, Pieper PG, Roos-Hesselink JW, Zwinderman AH, van Veldhuisen DJ, Mulder BJ. Outcome of pregnancy in patients after repair of aortic coarctation. Eur Heart J. 2005;26:2173-2178.

1.4.     Meijer JM, Pieper PG, Drenthen W, Voors AA, Roos-Hesselink JW, van Dijk AP, Mulder BJ, Ebels T, van Veldhuisen DJ. Pregnancy, fertility, and recurrence risk in corrected tetralogy of Fallot. Heart. 2005 Jun;91(6):801-5.

1.5.     Meijboom LJ, Drenthen W, Pieper PG, Groenink M, Post van der JAM, Timmermans J, Voors AA, Roos-Hesselink JW, Veldhuisen van DJ,Mulder BJM. Obstetric complications in the Marfan syndrome. Int J Cardiol. 2006;110:53-59.  

1.6.     Drenthen W, Pieper PG, Roos-Hesselink JW, Zoon N, Voors AA, Mulder BJ, van Dijk AP, Vliegen HW, Sollie KM, Ebels T, van Veldhuisen DJ; ZAHARA Investigators. Fertility, pregnancy, and delivery after biventricular repair for pulmonary atresia with an intact ventricular septum. Am J Cardiol. 2006 Jul 15;98(2):259-61.

1.7.     Drenthen W, Pieper PG, Roos-Hesselink JW, van Lottum WA, Voors AA, Mulder BJ, van Dijk AP, Vliegen HW, Sollie KM, Moons P, Ebels T, van Veldhuisen DJ; ZAHARA Investigators. Pregnancy and delivery in women after Fontan palliation. Heart. 2006 Sep;92(9):1290-4.

1.8.     Drenthen W, Pieper PG, Roos-Hesselink JW, Schmidt AC, Mulder BJ, van Dijk AP, Vliegen HW, Sollie KM, Voors AA, Ebels T, van Veldhuisen DJ; ZAHARA investigators. Non-cardiac complications during pregnancy in women with isolated congenital pulmonary valvar stenosis. Heart 2006 Dec; 92(12):1838-43.

1.9.     Drenthen W, Pieper PG, Zoon N, Roos-Hesselink JW, Voors AA, Mulder BJ, van Dijk AP, Sollie KM, Vliegen HW, Ebels T, van Veldhuisen DJ; ZAHARA Investigators. Pregnancy after biventricular repair for pulmonary atresia with ventricular septal defect. Am J Cardiol. 2006 Jul 15; 98(2):262-6.

1.10.   Drenthen W, Pieper PG, Roos-Hesselink JW, Zoon N, Voors AA, Mulder BJ, van Dijk AP, Vliegen HW, Sollie KM, Ebels T, van Veldhuisen DJ; ZAHARA Investigators. Fertility, pregnancy, and delivery after biventricular repair for pulmonary atresia with an intact ventricular septum. Am J Cardiol. 2006 Jul 15;98(2):259-61.

1.11.   Drenthen W, Pieper PG, Roos-Hesselink JW, van Lottum WA, Voors AA, Mulder BJ, van Dijk AP, Vliegen HW, Yap SC, Moons P, Ebels T, van Veldhuisen DJ; ZAHARA Investigators. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol. 2007 Jun 19;49(24):2303-11.

1.12.   Drenthen W, Pieper PG, van der Tuuk K, Roos-Hesselink JW, Hoendermis ES, Voors AA, Mulder BJ, van Dijk AP, Yap SC, Vliegen HW, Moons P, Ebels T, van Veldhuisen DJ Fertility, Pregnancy and Delivery in Women after Biventricular Repair for Double Outlet Right Ventricle.Cardiology. 2007 Aug 14;109(2):105-109.

1.13.   Yap SC, Drenthen W, Pieper PG et al. Risk of complications during pregnancy in women with congenital aortic stenosis. Int J Cardiol 2008 May 23;126(2):240-6.

1.14.   Drenthen W, Hoendermis ES, Moons P et al. Menstrual cycle and its disorders in women with congenital heart disease. Congenit Heart Dis 2008 July;3(4):277-83.

1.15.   Yap SC, Drenthen W, Pieper PG et al. Outcome of pregnancy in women after pulmonary autograft valve replacement for congenital aortic valve disease. J Heart Valve Dis 2007 July;16(4):398-403.

1.16.   Drenthen W, Pieper PG, van der Tuuk K, et al. Fertility, pregnancy and delivery in women after biventricular repair for double outlet right ventricle. Cardiology 2008;109(2):105-9.

1.17.   Drenthen W, Pieper PG, Roos-Hesselink JW et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol 2007 June 19;49(24):2303-11.

1.18.   Yap SC, Drenthen W, Pieper PG et al. Risk of complications during pregnancy in women with congenital aortic stenosis. Int J Cardiol 2008 May 23;126(2):240-6.

2.     Dr. H.L. Tan, AMC Amsterdam: “Genetic basis of cardiac malformations”

3.    Dr. J. Roos – Hesselink, Erasmus MC Rotterdam: “Molecular etiology LVOT obstruction”

4.    Dr. JW Roos-Hesselink, ErasmusMC, Rotterdam: “Follow-up patients with an AICD.”

4.1.     Sing-Chien Yap, Jolien W. Roos-Hesselink, Elke S. Hoenermis, Werner Budts, Hubert W.Vliegen, Barbara J.M. Mulder, Arie P. van Dijk, Martin Schalij, W. Drenthen. Outcome of implantable cardioverter defibrillators in adults with congenital heart disease: a multi-centre study. Eur Heart J. 2007 Aug;28(15):1854-61.

5.    Drs. M. Kriek, LUMC Leiden: “Identification of genes involved in congenital heart malformations"  

6.    Dr. R.H. Lekanne Deprez, AMC Amsterdam: “Genetic basis of congenital cardiac malformations”

7.    Prof.Dr. K. Devriendt, KU Leuven, Belgium: “PA26, candidategen heterotaxia”

8.    Prof.dr. B.J.M. Mulder, AMC Amsterdam: “Echocardiographic follow-up of pulmonary homograft function late after initial implantation”  

8.1.   Oosterhof T, Mulder BJ, Vliegen HW, de Roos A. Corrected tetralogy of Fallot: delayed enhancement in right ventricular outflow tract. Radiology. 2005 Dec;237(3):868-71.

8.2.   Oosterhof, T, Meijboom, FJ, Vliegen, HW, Hazekamp, MG, Zwinderman, AH, Bouma, BJ, van Dijk, AP Mulder, BJ: Long-term follow-up of homograft function after pulmonary valve replacement in patients with tetralogy of Fallot. Eur Heart J.  2006 Jun;27(12):1478-84.

8.3.   Oosterhof T, Vliegen HW, Meijboom FJ, Zwinderman AH, Bouma B, Mulder BJ. Long-term effect of pulmonary valve replacement on QRS duration in patients with corrected tetralogy of Fallot. Heart. 2007 Apr;93(4):506-9.Oct 25.

8.4.   Oosterhof T, van Straten A, Vliegen HW, Meijboom FJ, van Dijk AP, Spijkerboer AM, Bouma BJ, Zwinderman AH, Hazekamp MG, de Roos A, Mulder BJ. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation. 2007 Jul 31;116(5):545-51.

8.5.   Oosterhof T, Jacobs M, Cramer MJ, Mulder BJ. Survival into seventh decade after a potts palliation for tetralogy of Fallot. Congenit Heart Dis 2007 January;2(1):55-7.

9.    Dr. A.V. Postma, AMC Amsterdam: “GATA4 polymorphisms in congenital heart disease”

10.  Dr. J. Bakkers, Hubrecht Laboratorium Utrecht: “From zebrafish to man: Mutation discovery in genes required for normal cardiac development”   

11.  Dr. J.W. Roos-Hesselink, Erasmus MC, Rotterdam: “Prospective randomised multicentre study: statines and aortic stenosis”

12.  Prof R.Berger , UMCG, Groningen: “TGF-β receptor mutations in ASD”   

13.  Prof.dr. B.J.M. Mulder, AMC, Amsterdam: “Pulmonary arterial hypertension”

13.1.   Duffels MGJ, Engelfriet PM, Berger RMF, van Loon RLE, Hoendermis E, Vriend JWJ, van der Velde ET, Bresser P, Mulder BJM. Pulmonary arterial hypertension in congenital heart disease: An epidemiologic perspective from a Dutch registry. Int J Cardiol 2007 Aug 21;120(2):198-204.

13.2.   M.G.J. Duffels, R.M.F. Berger, P. Bresser, H.A.C.M. de Bruin-Bon, E. Hoendermis, B.J. Bouma, B.J.M. Mulder. Applicability of bosentan in Dutch patients with Eisenmenger syndrome: preliminary results on safety and exercise capacity. Neth Heart J. 2006 May 14 (5): 165-70.

13.3.   van Loon RL, Hoendermis ES, Duffels MG, Vonk-Noordegraaf A, Mulder BJ, Hillege HL, Berger RM. Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist? Am Heart J. 2007 Oct;154(4):776-82.

13.4.   Duffels MG, Vis JC, van Loon RL et al. Down patients with Eisenmenger syndrome: Is bosentan treatment an option? Int J Cardiol 2008 June 23.

13.5.   Hamaker ME, Duffels MG, Reichert CL, Cornel JH, Mulder BJ, Umans VA. [Two patients with Eisenmenger syndrome treated with novel agents that target vasodilation of the pulmonary capillary bed]. Ned Tijdschr Geneeskd 2007 August 11;151(32):1795-9.

13.6.   van der Plas MN, Duffels MG, Ponse D, Mulder BJ, Bresser P. Bosentan in mild pulmonary hypertension. Lancet 2008 November 15;372(9652):1730

13.7.   Duffels MG, Vis JC, van Loon RL et al. Effect of bosentan on exercise capacity and quality of life in adults with pulmonary arterial hypertension associated with congenital heart disease with and without Down’s syndrome. Am J Cardiol 2009 May 1;103990:1309-15

13.8.     Duffels MG, Mulder KM, Trip MD, de Groot E, Gort J, van Dijk AP, Hoendermis ES, Daliento L, Zwinderman AH, Berger RM, Mulder BJ. Atherosclerosis in patients with cyanotic congenital heart disease. Circ J. 2010;74(7):1436-41.

13.9.     Mulder BJ.Changing demographics of pulmonary arterial hypertension in congenital heart disease. Eur Respir Rev. 2010 Dec 1;19(118):308-13.

13.10.   Duffels M, van Loon L, Berger R, Boonstra A, Vonk-Noordegraaf A, Mulder B. Pulmonary arterial hypertension associated with a congenital heart defect: advanced medium-term medical treatment stabilizes clinical condition. Congenit Heart Dis. 2007 Jul;2(4):242-9.

14.  Dr. A. Hoffmann, Universiteit Basel, “A multicenter retrospective analysis on cerebrovascular accidents in a population of adults with congenital heart disease”.

15.  Dr A.Van Dijk , UMCN, Nijmegen: “ Morbus Ebstein”

16.  Prof Grobbee, Dr. C.Uiterwaal, Julius Centrum, Utrecht: “Prognosis in congenital heart disease”

16.1.   Verheugt CL, Uiterwaal CS, van der Velde ET, et al. Gender and outcome in adult congenital heart disease. Circulation 2008 July 1;118(1):26-32.

16.2.   Verheugt CL, Uiterwaal CS, Grobbee DE, Mulder BJ. Long-term prognosis of congenital heart defects: A systematic review. Int J Cardiol 2008 August 5.

16.3.     Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, Veen G, Stappers JL, Grobbee DE, Mulder BJ. Turning 18 with congenital heart disease: prediction of infective endocarditis based on a large population. Eur Heart J. 2011 Jan 8.

16.4.     Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, Sieswerda GT, Plokker HW, Grobbee DE, Mulder BJ. The emerging burden of hospital admissions of adults with congenital heart disease. Heart. 2010 Jun;96(11):872-8.

16.5.     Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, van Dijk AP, Vliegen HW, Grobbee DE, Mulder BJ. Mortality in adult congenital heart disease. Eur Heart J. 2010 May;31(10):1220-9.

17.  Prof BJM Mulder, AMC,Amsterdam: “CVA bij ASD”

17.1 Lok SI, Winkens B, Dimpoulos K et al. Recurrence of cerebrovascular events in Young adults with a secundum arterial septal defect, Int J Cardiol 2009 January 24

18.  Prof.dr. B.J.M. Mulder, prof AF Moorman, AMC, Amsterdam: “Heart failure and cardiac repair; genes for heart repair and plasticity”

18.1.     van Engelen K, Topf A, Keavney BD, Goodship JA, van der Velde ET, Baars MJ, Snijder S, Moorman AF, Postma AV, Mulder BJ. 22q11.2 Deletion Syndrome is under-recognised in adult patients with tetralogy of Fallot and pulmonary atresia. Heart. 2010 Apr;96(8):621-4.

18.2.     van Engelen K, Baars MJ, van Rongen LT, van der Velde ET, Mulder BJ, Smets EM. Adults with congenital heart disease: Patients' knowledge and concerns about inheritance. Am J Med Genet A. 2011 Jun 10. doi: 10.1002/ajmg.a.34068. [Epub ahead of print]

19.  Dr A. V. Postma: “Replication cohort for SNP studies in Tetralogy of Fallot”

20.  Dr A. van Dijk, UMCN, Nijmegen: “Exercise in Congenital heart disease”

21.  Dr.Postma AMC,Amsterdam, Denmark: “Genes in Aortic Stenosis”

22.  Prof AAM Wilde, AMC, Amsterdam: “Sodium channels in septal defects”

23.  Prof BJM Mulder, AMC, Amsterdam: “Congenital heart defects inDown syndrome”

23.1.   Vis JC, de Bruin-Bon RH, Bouma BJ, Huisman SA, Imschoot L, van den Brink K, Mulder BJ. Congenital heart defects are under-recognised in adult patients with Down's syndrome. Hearts. 2010 Sep;96(18):1480-4.

23.2.   Vis JC, Thoonsen H, Duffels MG, de Bruin-Bon RA, Huisman SA, van Dijk AP, Hoendermis ES,Berger RM, Bouma BJ, Mulder BJ. Six-minute walk test in patients with Down syndrome: validity and reproducibility.Arch Phys Med Rehabil. 2009 Aug;90(8):1423-7.

24.  Seshadri Balaji, Maully Shah, Dr. Roos-Hesselink Philadelphia/Rotterdam, “Arrhythmia after the Fontan operation:Comparison of the intracardial lateral Tunnel, and the extracardiac conduits procedures.

25.  Prof BJM Mulder, Prof AH Zwinderman: “Losartan in Marfan syndrome“

25.1.   Lilian J. Meijboom, Janneke Timmermans, Aeiko H. Zwinderman, Peter M. Engelfriet and Barbara J.M. Mulder. Aortic Root Growth in Men and Women with the Marfan’s Syndrome. J Cardiol. 2005 Nov 15; 96 (10)

25.2.   Meijboom LJ, Vos FE, Timmermans J, Boers GH, Zwinderman AH, Mulder BJ Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. Eur Heart J. 200 May;26(9): 914-20.

25.3.   Meijboom LJ, Timmermans J, van Tintelen JP, Nollen GJ, De Backer J, van den Berg MP, Boers GH, Mulder BJ Evaluation of left ventricular dimensions and function in Marfan’s syndrome without significant valvular regurgitation. Am J Cardiol. 2005 Mar 15;95(6):795-7

25.4.   deBackerJ , Nollen GJ, Devos D, Pals G, Coucke P, Verstraete K, van der Wall EE, Daepe A, Mulder BJ. Variability of aortic stiffness is not associated with the fibrillin 1 genotype in patients with Marfan's syndrome. Heart. 2006 Jul;92(7):977-8.

25.5.   Engelfriet PM, Mulder BJM. Is there benefit of beta-blocking agents in the treatment of patients with the Marfan syndrome? Int J Cardiol. 2007 Jan 18;114(3):300-2. Epub 2006 Jun 12

25.6.   Radonic T, de Witte P, Groenink M, de Bruin-Bon RA, Timmermans J, Scholte AJ, van den Berg MP, Baars MJ, van Tintelen JP, Kempers M, Zwinderman AH, Mulder BJ. Critical Appraisal of the Revised Ghent Criteria for Diagnosis of Marfan Syndrome. Int J Clin Genet. 2011 Feb 17.

25.7.   Radonic T, de Witte P, Baars MJ, Zwinderman AH, Mulder BJ, Groenink M; COMPARE study group. Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial. Int J Journal Date.

25.7.   Radonic T, de Witte P, Baars MJ, Zwinderman AH, Mulder BJ, Groenink M; COMPARE study group. Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial. Int J Journal Date.

26.  Dr BJ Bouma, Prof BJM Mulder, AMC, Amsterdam: “Statins in Aortic Coarctation”

26.1.   Vis JC, Duffels MG, Winter MM et al. Down syndrome: a cardiovasculair perspective. J Intellect Disabil Res 2009 May; 53(5):419-25.

27.  Prof Gittenberger, LUMC, Leiden, FP7: “Genes in heart valve development”

28.  Drs. M.M. Winter, Dr BJ.Bouma, Prof BJM Mulder: “Angiotensin II receptor blockers in patients with a systemic right ventricle”

28.1.   Winter MM, Bernink FJ, Groenink M et al. Evaluating the systemic right ventricle by CMR: the importance of consistent and reproducible delineation of the cavity. J Cardiovasc Magn Reson 2008;10(1):40.

28.2.   Winter MM, Bouma BJ, van Dijk AP et al. Relation of physical activity, cardiac function, exercise capacity, and quality of life in patients with a systemic right ventricle. Am J Cardiol 2008 November 1; 102(9): 1258-62

28.3.   Winter MM, van der Plas MN, Bouma BJ, Groenink M, Bresser P, Mulder BJ. Mechanisms for cardiac output augmentation in patients with a systemic right ventricle. Int. J.Cardiol 2009 February 22

28.4.   Winter MM, Mulder BJ, van der Velde ET. Letter by Winter et al regarding article, "Children and adults with congenital heart disease lost to follow-up: who and when?". Circulation. 2010 Mar 30;121 (12):e252. PMID: 2035130

28.5.     Winter MM, Reisma C, Kedde H, Bouma BJ, Vis JC, Luijendijk P, de Witte P, Zwinderman AH, Vliegen HW, Pieper PG, van Dijk AP, Mulder BJ. Sexuality in adult patients with congenital heart disease and their partners. Am J Cardiol. 2010 Oct 15;106(8):1163-8, 1168.e1-8.

28.6.     Winter MM, Scherptong RW, Kumar S, Bouma BJ, Tulevski II, Tops LF, Roest AA, Vliegen HW, de Roos A, Groenink M, Mulder BJ. Ventricular response to stress predicts outcome in adult patients with a systemic right ventricle. Am Heart J. 2010 Nov;160(5):870-6.

28.7.     van der Bom T, Winter MM, Bouma BJ, Groenink M, Vliegen HW, Pieper PG, van Dijk AP, Sieswerda GT, Roos-Hesslink JW, Zwinderman AH, Mulder BJ. Rationale and design of a trial on the effect of angiotensin II receptor blockers on the function of the systemic right ventricle. Am Heart J. 2010 Nov;160(5):812-8.

28.8.     van der Bom T, Zomer AC, Zwinderman AH, Meijboom FJ, Bouma BJ, Mulder BJ. The changing epidemiology of congenital heart disease. Nat Rev Cardiol. 2011 Jan;8(1):50-60.

28.9.     van der Bom T, Luijendijk P, Bouma BJ, Koolbergen DR, de Groot JR, Mulder BB. Treatment of congenital heart disease: risk-reducing measures in young adults. Future Cardiol. 2011 Mar;7(2):227-40.

28.10.     Winter MM, van der Bom T, de Vries LC, Balducci A, Bouma BJ, Pieper PG, van Dijk AP, van der Plas MN, Picchio FM, Mulder BJ. Exercise training improves exercise capacity in adult patients with a systemic right ventricle: a randomized clinical trial. Eur Heart J. 2011 Oct 27

29.  Prof Willekens, Dr L. /Bonneux, NIDI / KNAW, Den Haag: “Demography in CHD”

30.  Prof Bhattacharya, J.Goodship, Oxford, UK: “Genetic architecture of Congenital heart disease”

31.  Dr. P.G.Pieper, UMCG Groningen,“Pregnancy in congenital heart disease (ZAHARA2)”.

31.1.     Balci A, Drenthen W, Mulder BJ, Roos-Hesselink JW, Voors AA, Vliegen HW, Moons P, Sollie KM, van Dijk AP, van Veldhuisen DJ, Pieper PG. Pregnancy in women with corrected tetralogy of Fallot: occurrence and predictors of adverse events. Am Heart J. 2011 Feb;161(2):307-13. Epub 2011 Jan 15.

31.2.     Balci A, Sollie KM, Mulder BJ, de Laat MW, Roos-Hesselink JW, van Dijk AP, Wajon EM, Vliegen HW, Drenthen W, Hillege HL, Aarnoudse JG, van Veldhuisen DJ, Pieper PG. Associations between cardiovascular parameters and uteroplacental Doppler (blood) flow patterns during pregnancy in women with congenital heart disease: Rationale and design of the Zwangerschap bij Aangeboren Hartafwijking (ZAHARA) II study. Am Heart J. 2011 Feb;161(2):269-275.e1.

32.  Prof.dr. I.C. van Gelder, UMC Groningen. “Arrhythmias in adults with CHD”.

32.1.     Koyak Z, de Groot JR, Mulder BJ. Interventional and surgical treatment of cardiac arrhythmias in adults with congenital heart disease. Expert Rev Cardiovasc Ther. 2010 Dec;8(12):1753-66.

32.2.     Koyak Z, de Groot JR, Van Gelder IC, Bouma BJ, van Dessel PF, Budts W, van Erven L, van Dijk AP, Wilde AA, Pieper PG, Sieswerda GT, Mulder BJ. Implantable Cardioverter Defibrillator Therapy in Adults with Congenital Heart Disease: Who is at Risk of Shocks? Circ Arrhythm Electrophysiol. 2011 Nov 17.

33.  Drs. A.W. Schadenberg UMC Utrecht “Neonatal thymectomy during heart surgery: consequences for the immune system in patients with TGA”

34.  Drs. Joziasse, UMC Utrecht. Genemutations in patients with TGA.

34.1.   Joziasse IC, van de Smagt JJ, Smith K et al. Genes in congenital heart disease: atrioventricular valve formation. Basic Res Cardiol 2008 May;103(3):216-27.

34.2.   Joziasse IC, van der Smagt, JJ Poot M et al. A duplication including GATA4 does not co-segregate with congenital heart defects. Am J Med Genet 2009 May; 149A(5):1062-6

34.3.   Smith KA, Joziasse IC, Chocron S et al. Dominant-negative ALK2 allele associates with congenital heart defects. Circulation 2009 June 23:119(24):3062-9

35.  Prof. BJM Mulder, Drs. K.v.Engelen, Dr. AV Postma; AmsterdamGATA5 a new congenital heart defect gene

36.  Drs. J.C. Vis, Drs. MJ Schuuring AMC AmsterdamMarfan and Migraine

36.1.   Vis JC, Timmermans J, Post MC et al. Increased prevalence of migraine in Marfan syndrome. Int J Cardiol 2008 August 2.

36.2.     Schuuring MJ, Vis JC, Duffels MG, Bouma BJ, Mulder BJ. Adult patients with pulmonary arterial hypertension due to congenital heart disease: a review on advanced medical treatment with bosentan. Ther Clin Risk Manag. 2010 Sep 7;6:359-66.

36.3.     Schuuring MJ, Bolmers PP, Mulder BJ, de Bruin-Bon RA, Koolbergen DR, Hazekamp MG, Lagrand WK, De Hert SG, de Beaumont EM, Bouma BJ. Right ventricular function declines after cardiac surgery in adult patients with congenital heart disease. Journal and Date

36.4.     Schuuring MJ, Vis JC, Bouma BJ, van Dijk AP, van Melle JP, Pieper PG, Vliegen HW, Sieswerda GT, Mulder BJ. Rationale and design of a trial on the role of bosentan in Fontan patients: Improvement of exercise capacity? Journal and Date

36.5.     Schuuring MJ, Boekholdt SM, Windhausen A, Bouma BJ, Groenink M, Keijzers M, De Winter RJ, Koolbergen DR, Blom NA, Mulder BJ. Advanced therapy for ulmonary arterial hypertension due to congenital heart disease: a clinical perspective in a new therapeutic era. Neth Heart J. 2011 Nov 16.

36.6.     Schuuring MJ, van Riel AC, Bouma BJ, Mulder BJ. Recent progress in treatment of pulmonary arterial hypertension due to congenital heart disease. Neth Heart J. 2011 Nov 12.

37.  Drs. D. Schoormans, AMC Amsterdam “ PREDICTING HEALTH CARE USE AND PERCEIVED HEALTH CARE NEEDS IN PATIENTS WITH CONGENITAL DISEASE.

37.1.     Schoormans D, Sprangers MA, Pieper PG, van Melle JP, van Dijk AP, Sieswerda GT, Hulsbergen-Zwarts MS, Plokker TH, Brunninkhuis LG, Vliegen HW, Mulder BJ. The Perspective of Patients with Congenital Heart Disease: Does Health Care Meet Their Needs? Congenit Heart Dis. 2011 May;6(3):219-227. doi: 10.1111/j.1747-0803.2011.00521.x. Epub 2011 May 5.

38.  Drs. C. Zomer AMC Amsterdam “Facing the furture of adults with congenital heart disease”

38.1.     Zomer AC, Uiterwaal CS, der Velde ET, Tijssen JG, Mariman EC, Verheugt CL, Vaartjes I, Pieper PG, Meijboom FJ, Grobbee DE, Mulder BJ. Mortality in adult congenital heart disease: Are national registries reliable for cause of death? Int J Cardiol. 2010 Jul 30.

38.2.     Zomer AC, Vaartjes I, Uiterwaal CS, van der Velde ET, van den Merkhof LF, Baur LH, Ansink TJ, Cozijnsen L, Pieper PG, Meijboom FJ, Grobbee DE, Mulder BJ. Circumstances of death in adult congenital heart disease. Int J Cardiol. 2010 Oct 7.

38.3.     Zomer AC, Verheugt CL, Vaartjes I, Uiterwaal CS, Langemeijer MM, Koolbergen DR, Hazekamp MG, van Melle JP, Konings TC, Bellersen L, Grobbee DE, Mulder BJ. Surgery in Adults With Congenital Heart Disease. Circulation. 2011 Oct 10

39.  Prof. P. Doevendans UMC Utrecht “Genomics of the arterial pole”

40.  Mw.Dr. P.G. Pieper UMC Groningen “Functional outcome and quality of life in adult congenital heart disease patients with prosthetic valves”

35.  Drs. ACMJ v Riel, Amsterdam Epidemiology and early detection of PAH in CHD.

 

Other publications
  1. Vis JC, Timmermans J, Post MC et al. Increased prevalence of migraine in Marfan syndrome. Int J Cardiol 2008 August 2.
  2. Van der Velde ET, Vriend JW, Mannens MM, Uiterwaal CS, Brand R, Mulder BJ. CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: rationale, design, and first results. Eur J Epidemiol. 2005;20(6):549-57.
  3. Vriend JW, van der Velde ET, Mulder BJ. [National registry and DNA-bank of patients with congenital heart disease: the CONCOR-project]. Ned Tijdschr Geneeskd. 2004 Aug 14;148(33):1646-7.
  4. Van der Velde ET, Vriend JWJ, Theeuwes E, Murk Jansen HDM, Kuiper J, Hoekstra WHGJ, Mulder BJM: Quality assurance measures in the CONCOR national registry and DNA-bank of patients with congenital heart disease in the Netherlands. Computers in Cardiology 30: 395-398, 2003.
  5. Meijboom F, Mulder B. Problems in the organization of care for patients with adult congenital heart disease. Arch Cardiovasc Dis. 2010 Jun-Jul; 103(6-7):411-5.